Regenerative Therapy (Jun 2015)

Oxidative stress tolerance of early stage diabetic endothelial progenitor cell

  • Dewi Sukmawati,
  • Satoshi Fujimura,
  • Sachie Jitsukawa,
  • Rie Ito-Hirano,
  • Takamasa Ishii,
  • Tadayuki Sato,
  • Ayato Hayashi,
  • Seigo Itoh,
  • Hiroshi Mizuno,
  • Hiroyuki Daida,
  • Rica Tanaka

DOI
https://doi.org/10.1016/j.reth.2014.11.001
Journal volume & issue
Vol. 1, no. C
pp. 38 – 44

Abstract

Read online

Introduction: One of the causes for poor vasculogenesis of diabetes mellitus (DM) is known to rise from the dysfunction of bone marrow-derived endothelial progenitor cells (BM EPCs). However, the origin of its cause is less understood. We aimed to investigate the effect of oxidative stress in early stage of diabetic BM-EPC and whether its vasculogenic dysfunction is caused by oxidative stress. Methods: Bone marrow c-Kit+Sca-1+Lin− (BM-KSL) cells were sorted from control and streptozotocin-induced diabetic C57BL6J mice by flow cytometry. BM-KSLs were then assessed for vasculogenic potential (colony forming assay; EPC-CFA), accumulation of intracellular ROS (CM-H2DCFDA), carbonylated protein (ELISA), anti-oxidative enzymes expression (RT-qPCR) and catalase activity (Amplex Red). Results: Compared to control, DM BM-KSL had significantly lower EPC-CFUs in both definitive EPC-CFU and total EPC-CFU (p < 0.05). Interestingly, the oxidative stress level of DM BM-KSL was comparable and was not significantly different to control followed by increased in anti-oxidative enzymes expression and catalase activity. Conclusions: Primitive BM-EPCs showed vasculogenic dysfunction in early diabetes. However the oxidative stress is not denoted as the major initiating factor of its cause. Our results suggest that primitive BM-KSL cell has the ability to compensate oxidative stress levels in early diabetes by increasing the expression of anti-oxidative enzymes.

Keywords